| Solstice Counseling & Wellness | |
|
722 W 100 S Ste 1 Heber City UT 84032-3739 | |
| (435) 654-4037 | |
| (435) 654-4077 |
| Full Name | Solstice Counseling & Wellness |
|---|---|
| Speciality | Psychologist |
| Location | 722 W 100 S Ste 1, Heber City, Utah |
| Authorized Official Name and Position | Shawn Michael Miller (PSYCHOLOGIST) |
| Authorized Official Contact | 4356544037 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Solstice Counseling & Wellness 722 W 100 S Ste 1 Heber City UT 84032-3739 Ph: (435) 654-4037 | Solstice Counseling & Wellness 722 W 100 S Ste 1 Heber City UT 84032-3739 Ph: (435) 654-4037 |
| NPI Number | 1710227608 |
|---|---|
| Provider Enumeration Date | 03/01/2013 |
| Last Update Date | 05/17/2013 |
| Medicare PECOS PAC ID | 8426296724 |
|---|---|
| Medicare Enrollment ID | O20130528000564 |
News Archive
A growth factor receptor found abundantly on the surface of cancer cells and long known to fuel cancer growth also protects tumor cells from starvation by a newly identified mechanism, researchers at The University of Texas M. D. Anderson Cancer Center report in the May 5 issue of Cancer Cell.
University of Minnesota researchers have discovered that people with high oxidation levels of the low-density lipoprotein (LDL) particle that carries cholesterol throughout the blood are much more likely to develop metabolic syndrome - which can lead to a considerably increased risk of developing heart disease.
Decision Resources, Inc., forecasts that Amgen's novel biological agent for the treatment of osteoporosis, AMG-162, will become a blockbuster by 2013. Premium pricing of AMG-162 will propel the sales of this agent.
Rare Disease Therapeutics, Inc. (RDT), the producer of orphan pharmaceuticals for the treatment of rare diseases, announced today that they have received FDA approval for PURIXAN™ (mercaptopurine) 20 mg/mL oral suspension--a new, easier-to-dose, liquid form of an established treatment for patients with Acute Lymphoblastic Leukemia (ALL).
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710227608 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | (* (Not Available)) | Primary |
| Provider Name | Shawn M Miller |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1861605834 PECOS PAC ID: 6305012188 Enrollment ID: I20120514000266 |
News Archive
A growth factor receptor found abundantly on the surface of cancer cells and long known to fuel cancer growth also protects tumor cells from starvation by a newly identified mechanism, researchers at The University of Texas M. D. Anderson Cancer Center report in the May 5 issue of Cancer Cell.
University of Minnesota researchers have discovered that people with high oxidation levels of the low-density lipoprotein (LDL) particle that carries cholesterol throughout the blood are much more likely to develop metabolic syndrome - which can lead to a considerably increased risk of developing heart disease.
Decision Resources, Inc., forecasts that Amgen's novel biological agent for the treatment of osteoporosis, AMG-162, will become a blockbuster by 2013. Premium pricing of AMG-162 will propel the sales of this agent.
Rare Disease Therapeutics, Inc. (RDT), the producer of orphan pharmaceuticals for the treatment of rare diseases, announced today that they have received FDA approval for PURIXAN™ (mercaptopurine) 20 mg/mL oral suspension--a new, easier-to-dose, liquid form of an established treatment for patients with Acute Lymphoblastic Leukemia (ALL).
› Verified 6 days ago
| Provider Name | Christian H Monson |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1649618307 PECOS PAC ID: 9133351406 Enrollment ID: I20140421000989 |
News Archive
A growth factor receptor found abundantly on the surface of cancer cells and long known to fuel cancer growth also protects tumor cells from starvation by a newly identified mechanism, researchers at The University of Texas M. D. Anderson Cancer Center report in the May 5 issue of Cancer Cell.
University of Minnesota researchers have discovered that people with high oxidation levels of the low-density lipoprotein (LDL) particle that carries cholesterol throughout the blood are much more likely to develop metabolic syndrome - which can lead to a considerably increased risk of developing heart disease.
Decision Resources, Inc., forecasts that Amgen's novel biological agent for the treatment of osteoporosis, AMG-162, will become a blockbuster by 2013. Premium pricing of AMG-162 will propel the sales of this agent.
Rare Disease Therapeutics, Inc. (RDT), the producer of orphan pharmaceuticals for the treatment of rare diseases, announced today that they have received FDA approval for PURIXAN™ (mercaptopurine) 20 mg/mL oral suspension--a new, easier-to-dose, liquid form of an established treatment for patients with Acute Lymphoblastic Leukemia (ALL).
› Verified 6 days ago
| Provider Name | Sofia M Chernoff |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1881103257 PECOS PAC ID: 0941566319 Enrollment ID: I20171117002400 |
News Archive
A growth factor receptor found abundantly on the surface of cancer cells and long known to fuel cancer growth also protects tumor cells from starvation by a newly identified mechanism, researchers at The University of Texas M. D. Anderson Cancer Center report in the May 5 issue of Cancer Cell.
University of Minnesota researchers have discovered that people with high oxidation levels of the low-density lipoprotein (LDL) particle that carries cholesterol throughout the blood are much more likely to develop metabolic syndrome - which can lead to a considerably increased risk of developing heart disease.
Decision Resources, Inc., forecasts that Amgen's novel biological agent for the treatment of osteoporosis, AMG-162, will become a blockbuster by 2013. Premium pricing of AMG-162 will propel the sales of this agent.
Rare Disease Therapeutics, Inc. (RDT), the producer of orphan pharmaceuticals for the treatment of rare diseases, announced today that they have received FDA approval for PURIXAN™ (mercaptopurine) 20 mg/mL oral suspension--a new, easier-to-dose, liquid form of an established treatment for patients with Acute Lymphoblastic Leukemia (ALL).
› Verified 6 days ago
News Archive
A growth factor receptor found abundantly on the surface of cancer cells and long known to fuel cancer growth also protects tumor cells from starvation by a newly identified mechanism, researchers at The University of Texas M. D. Anderson Cancer Center report in the May 5 issue of Cancer Cell.
University of Minnesota researchers have discovered that people with high oxidation levels of the low-density lipoprotein (LDL) particle that carries cholesterol throughout the blood are much more likely to develop metabolic syndrome - which can lead to a considerably increased risk of developing heart disease.
Decision Resources, Inc., forecasts that Amgen's novel biological agent for the treatment of osteoporosis, AMG-162, will become a blockbuster by 2013. Premium pricing of AMG-162 will propel the sales of this agent.
Rare Disease Therapeutics, Inc. (RDT), the producer of orphan pharmaceuticals for the treatment of rare diseases, announced today that they have received FDA approval for PURIXAN™ (mercaptopurine) 20 mg/mL oral suspension--a new, easier-to-dose, liquid form of an established treatment for patients with Acute Lymphoblastic Leukemia (ALL).
› Verified 6 days ago
Kintsugi Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 150 N Main St Ste 204, Heber City, UT 84032 Phone: 435-850-7402 Fax: 435-538-7000 | |
Marci Heugly Cmhc Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 322 E Gateway Dr Ste 102, Heber City, UT 84032 Phone: 435-649-4075 | |
Alliance Clinical Services, Llp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 175 N Main St Ste B1, Heber City, UT 84032 Phone: 435-657-9588 Fax: 435-657-9588 | |
Brenna M. Schaffer Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 950 E 600 S, Heber City, UT 84032 Phone: 435-671-3682 | |
Stillwater Psychology, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 950 E 600 S, Heber City, UT 84032 Phone: 435-671-3683 | |
Hidden Piece Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 486 Argyll Ct, Heber City, UT 84032 Phone: 435-315-2566 | |
Kennedy Behavior Consulting, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 210 S 1970 E Unit 238, Heber City, UT 84032 Phone: 435-709-6745 |